Eton Pharmaceuticals, Inc.
USD42.32
+5.13 (+13.79%)
CEO
Sean E. Brynjelsen
IPO Date
2018-11-14
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$37.11
Prev. Close
$37.19
Day Low
$37.00
Day High
$42.65
52W Low
$13.78
52W High
$42.65
Market Cap
$1.16B
Volume
1.28M
| 13,315 |
| $37.54 |
| 14 Jul 2026 | BRYNJELSEN SEAN | director, officer: President & CEO | M-Exempt | Acquired | 27,500 | $0.00 |
| 14 Jul 2026 | BRYNJELSEN SEAN | director, officer: President & CEO | M-Exempt | Acquired | 200,000 | $1.37 |
| 14 Jul 2026 | BRYNJELSEN SEAN | director, officer: President & CEO | M-Exempt | Disposed | 27,500 | $0.00 |
| 14 Jul 2026 | BRYNJELSEN SEAN | director, officer: President & CEO | M-Exempt | Acquired | 200,000 | $1.37 |
| 13 Jul 2026 | Krempa David | Chief Business Officer | M-Exempt | Acquired | 10,000 | $0.00 |
| 13 Jul 2026 | Krempa David | Chief Business Officer | M-Exempt | Disposed | 10,000 | $0.00 |
| 7 Jul 2026 | Opaleye Management Inc. | 10 percent owner | S-Sale | Disposed | 65,000 | $37.39 |
| 7 Jul 2026 | Opaleye Management Inc. | 10 percent owner | S-Sale | Disposed | 25,000 | $37.39 |